Enanta Pharmaceuticals (ENTA) Return on Equity [ROE] (2013 - 2026)
Enanta Pharmaceuticals' Return on Equity [ROE] came in at -58.10% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 48.38 percentage points from -106.48% a year earlier but down 7.12 percentage points from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Return on Equity [ROE] was -84.63%, down 17.46 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last seven fiscal years, with a five-year change of -76.75 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Equity [ROE] was -67.17% in FY2024 (-17.43 pp), -49.74% in FY2023 (-15.95 pp), -33.79% in FY2022 (-15.31 pp) and -18.48% in FY2021 (-10.60 pp).
- The five-year range for quarterly Return on Equity [ROE] is -113.74% (fiscal Q4 2025) to -22.81% (fiscal Q4 2021).
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of -3.03 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q3 2026 (a gain of 48.38 percentage points), and the weakest in fiscal Q3 2025 (a drop of 33.27 percentage points).
- Business Quant data shows ENTA's Return on Equity [ROE] at -50.98% (Q2 2026), -74.79% (Q1 2026) and -113.74% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Enanta Pharmaceuticals | 383.80 Mn | -344.19 Mn | - | -58.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.10% |
| Mar 31, 2026 | -50.98% |
| Dec 31, 2025 | -74.79% |
| Sep 30, 2025 | -113.74% |
| Jun 30, 2025 | -106.48% |
| Mar 31, 2025 | -93.90% |
| Dec 31, 2024 | -87.21% |
| Sep 30, 2024 | -83.57% |
| Jun 30, 2024 | -73.22% |
| Mar 31, 2024 | -73.60% |
| Dec 31, 2023 | -67.66% |
| Sep 30, 2023 | -58.88% |
| Jun 30, 2023 | -52.07% |
| Mar 31, 2023 | -43.74% |
| Dec 31, 2022 | -38.78% |
| Sep 30, 2022 | -36.93% |
| Jun 30, 2022 | -34.45% |
| Mar 31, 2022 | -30.24% |
| Dec 31, 2021 | -29.34% |
| Sep 30, 2021 | -22.81% |
API Access
Enanta Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();